News

Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve

The LANDMARK trial continues to show positive outcomes for the TAVR valve made in India.

Boston Scientific said it initiated the AGENT DCB STANCE trial to assess the safety and effectiveness of the Agent Drug-Coated Balloon (DCB) compared to the standard of care using either percutaneous coronary intervention (PCI) with drug-eluting stents (DES) and/or balloon angioplasty. The trial will enroll more than 1,600 patients and is expected to a primary completion date in 2028.

Boston Scientific said two category III CPT codes are set to become permanent category I codes for physician payments starting Jan. 1, 2027. 

Apple has officially introduced the Apple Watch Ultra 3, which will provide notifications when it detects signs of chronic high blood pressure once the technology is cleared by the U.S. Food and Drug Administration (FDA).

Masimo’s complaint over the new version of the Apple Watch could lead to an import ban if it is found that the technology infringes on its patents.

Society of Cardiovascular Angiography and Interventions (SCAI) President Srihari S. Naidu, MD, professor of medicine at New York Medical College, explains the SCAI initiative to improve outcomes in cardiogenic shock by monitoring and lowering patient lactate levels.

SCAI feels this is the best way forward to try lowering mortality rates, but the group is asking cardiologists to help by gathering more data. 

The agreement also will make Boston Scientific the exclusive distributor for the new ICE catheter optimized for left atrial appendage occlusion workflows.

The U.S. Food and Drug Adminstration (FDA) granted 510(k) clearance for the latest release of Philips Healthcare's Cardiovascular Workspace imaging and information management system. It enables cloud-hosted availability and software-as-a-Service (SaaS) deployment.

The cloud-enabled system provides the foundation for future AI-enabled tools, better workflows and analytics.

Physicians often tell AFib patients they should limit coffee consumption to protect their hearts. This new analysis, however, suggests that may not be necessary.

Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes. 

Thumbnail

Once the tool's performance is properly validated, it could help clinicians deliver better patient care and result in significant cost savings for health systems.

The findings, to be presented at AHA Scientific Sessions 2021, focused on methamphetamines, opiates, cocaine, cannabis and alcohol. 

Robert Califf, MD, is a practicing cardiologist and professor of cardiology at the Duke University School of Medicine. 

Around the web

Researchers recently used advanced 4D flow MRI to track blood in a pulsating artificial heart, revealing dynamics that closely mirror those of a healthy human organ.

Congress needs to act soon to extend telemedicine services that were greatly expanded under COVID provisions, or they will expire by October. Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains concerns raised by doctors and lawmakers.

 

Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains the political and patient care issues involved with ending Affordable Care Act subsidies.